The relationship of electrocardiographic left ventricular hypertrophy to decreased serum potassium

Blood Pressure

Volumn 21, Issue 3, 2012, Pages 146-152

  Okin, Peter M ^a   Kjeldsen, Sverre E ^b,c   Lindholm, Lars H ^d   Dahlöf, Björn ^e   Devereux, Richard B ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d UMEÅ UNIVERSITY   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hypertension; hypertrophy; hypokalemia; potassium

Indexed keywords

ALBUMIN; ATENOLOL; CREATININE; HYDROCHLOROTHIAZIDE; LOSARTAN; POTASSIUM;

ADD ON THERAPY; ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DIURETIC THERAPY; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ATENOLOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; HYPOKALEMIA; LOSARTAN; MALE; PROSPECTIVE STUDIES;

EID: 84860844804     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2011.649537     Document Type: Article

References (39)

1. He FJ, MacGregor GA. Benefi cial effects of potassium on human health. Physiologia Plantarum. 2008;133:725-735. (Pubitemid 351977523)
2. Tell GS, Rutan GH, Kronmal RA, Bild DE, Polak JF, Wong ND, et al. Correlates of blood pressure in communitydwelling older adults: The Cardiovascular Health Study. Hypertension. 1994;23:59-67. (Pubitemid 24022045)
3. Barri Y, Wingo CS. The effects of potassium depletion and supplementation on blood pressure: A clinical review. Am J Med Sci. 1997;314:37-40. (Pubitemid 27295036)
4. Ray PE, Suga SI, Liu XH, Huang X, Johnson RJ. Chronic potassium depletion induces renal injury, salt sensitivity, and hypertension in young rats. Kidney Int. 2001;59:1850-1858. (Pubitemid 32336800)
5. Pikikidou MI, Lasaridis AN, Sarafi dis PA, Tziolas IM, Zebekakis PE, Dombros NV, et al. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment. Clin Exper Hyper. 2007;29:563-573. (Pubitemid 350223245)
6. Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follman D, et al. Effect of oral potassium on blood pressure: Metaanalysis of randomized controlled clinical trials. JAMA. 1997;277:1624-1632. (Pubitemid 27231195)
7. Krishna GG. Effect of potassium intake on blood pressure. J Am Soc Nephrol. 1990;1:43-52.
8. Walsh CR, Larson MG, Vasan RS, Levy D. Serum potassium is not associated with blood pressure tracking in the Framingham Heart Study. Am J Hypertens. 2002;15:130-136. (Pubitemid 34161087)
9. Srivastava TN, Young DB. Impairment of cardiac function by moderate potassium depletion. J Card Fail. 1995;1:195-200.
10. Fitzovich DE DE, Hamaguchi M, Tull WB, Young DB. Chronic hypokalemia and the left ventricular responses to epinephrine and preload. J Am Coll Cardiol. 1991;18:1105-1111.
11. Matsui H, Shimosawa T, Uetake Y, Wang H, Ogura S, Kaneko T, et al. Protective effect of potassium against the hypertensive cardiac dysfunction: Association with reactive oxygen species reduction. Hypertension. 2006;48:225-231. (Pubitemid 44309816)
12. Young DB. Potassium depletion and diastolic dysfunction. Hypertension. 2006;48:201-202. (Pubitemid 44309808)
13. Pere AK, Lindgren L, Tuomainen P, Korgerus L, Rauhala P, Laakso J, et al. Dietary potassium and magnesium supplementation in cyclosporine-induced hypertension and nephrotoxicty. Kidney Int. 2000;58:2462-2472.
14. Xie Z, Liu J, Malhotra, D, Sheridan T, Periyasamy SM, Shapiro JI. Effects of hypokalemia on cardiac growth. Ren fail. 2000;22:561-572.
15. Wang Q, Hummler E, Nussberger J, Clément S, Gabbiani G, Brunner HR, et al. Blood pressure, cardiac and renal responses to salt and deoxycorticosterone acetate in mice: Role of renin genes. J Am Soc Nephrol. 2002;13:1509-1516. (Pubitemid 34579240)
16. Wang Q, Domenighetti AA, Pedrazzini T, Burnier M. Potassium supplementation reduces cardiac and renal hypertrophy independent of blood pressure in DOCA/salt mice. Hypertension. 2005;46:547-554. (Pubitemid 41376836)
17. He FJ, Marciniak M, Carney C, Markandu ND, Anand V, Fraser WD, et al. Effects of potassium chloride and potassium bicarbonate on endothelial function, cardiovascular risk factors, and bone turnover in mild hypertensives. Hypertension. 2010;55:681-688.
18. Maciejewska M, Dabrowska B. Infl uence of serum potassium on the electrocardiographic pattern of left ventricular hypertrophy in primary hyperaldosteronism. Clin Cardiol. 1992;15: 725-727.
19. Cohen HW, Madhaven S, Alderman MH. High and low serum potassium associated with cardiovascular events in diuretic-treated patients. J Hypertens. 2001;19:1315-1323. (Pubitemid 32595289)
20. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, et al. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. J Am Coll Cardiol. 1998;31:383-390. (Pubitemid 28153459)
21. Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation. 1994;90:1786-1793. (Pubitemid 24320926)
22. Mathew J, Sleight P, Lonn E, Johnstone D, Pogue JM, Yi Q, et al. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation. 2001;104:1615-1621. (Pubitemid 32947523)
23. Hypertension Detection and Follow-up Program Cooperative Group. Five year fi ndings of the Hypertension Detection and Follow-up Program: Prevention and reversal of left ventricular hypertrophy with antihypertensive drug therapy. Hypertension. 1985;7:105-112.
24. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and prediction of major cardiovascular events: The LIFE Study. JAMA. 2004;292:2343-2349. (Pubitemid 39491918)
25. Okin PM, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, et al. Reduction of electrocardiographic left ventricular hypertrophy is associated with decreased heart failure hospitalization in hypertensive patients. Ann Intern Med. 2007;147:311-319. (Pubitemid 351664558)
26. Okin PM, Wachtell K, Devereux RB, Harris KE, Jern S, Kjeldsen SE, et al. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fi brillation: The LIFE Study. JAMA. 2006;296: 1242-1248. (Pubitemid 44394895)
27. Okin PM, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Lindholm LH, et al. In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: The LIFE Study. Hypertension. 2007;50:984-990. (Pubitemid 350287545)
28. Dahlöf B, Pennert K, Hannson L. Reversal of left ventricular hypertrophy in hypertensive patients: A meta-analysis of 109 treatment studies. Am J Hypertens. 1992;5:95-110.
29. Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens. 2008;21:500-508. (Pubitemid 351589672)
30. Schneider MP, Klingbeil AU, Delles C, Ludwig M, Kolloch RE, Krekler M, et al. Effect of irbesartan versus atenolol on left ventricular mass and voltage: Results of the CardioVascular Irbesartan Project. Hypertension. 2004;44:61-66. (Pubitemid 38823488)
31. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, et al. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The LIFE Study. Circulation. 2003;108:684-690.
32. Liebson PR, Grandits GA, Dianzumba S, Prineas RJ, Grimm RH Jr, Neaton JD, et al. Comparison of fi ve antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 1995;91:698-706.
33. Gottdiener JS, Reda DJ, Massie BM, Materson BJ, Williams DW, Anderson RJ, et al. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: Comparison of six antihypertensive agents. Circulation. 1997;95:2007-2014. (Pubitemid 27184266)
34. Meredith PA. Angiotensin II receptor antagonists alone and combined with hydrochlorothiazide: Potential benefi ts beyond the antihypertensive effect. Am J Cardiovasc Drugs. 2005;5: 171-183. (Pubitemid 40994271)
35. Okin PM, Hille DA, Kjeldsen SE, Lindholm LH, Edelman JM, Dahlöf B, et al. Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients and the interaction with losartan vs atenolol therapy: The LIFE Study. Am J Hypertens. 2010;23:786-93.
36. Materson BJ, Cushman WC, Goldstein G, Reda DJ, Freis ED, Ramirez EA, et al. Treatment of hypertension in the elderly: I. Blood pressure and clinical changes. Results of a Department of Veterans Affairs cooperative study. Hypertension. 1990;15:348-360. (Pubitemid 20137588)
37. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hyper tension study (LIFE): A randomised trial against atenolol. Lancet. 2002;359:995-1003. (Pubitemid 34286536)
38. Okin PM, Roman MJ, Devereux RB, Kligfi eld P. Electrocardiographic identifi cation of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol. 1995;25:417-423.
39. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;37:161-186.